CLASS 3 RECALL- LACIDIPINE 4MG TABLETS

Dr Reddy’s Laboratories (UK) Limited is recalling two batches of Lacidipine 4 mg Film-Coated Tablets as a precautionary measure due to the presence of an unknown solvent-like odour.

MHRA drug alert date: 18th January 2023

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-dr-reddys-laboratories-uk-ltd-lacidipine-4-mg-film-coated-tablets-el-23-a-slash-03?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2e503df5-1891-40b4-a054-1dd7fb232117&utm_content=immediately

Further Information

For medical information enquiries please contact Dr. Reddy’s Laboratories (UK) Ltd Medical Information Department at 01748 828873, or email drreddysGB@EU.ProPharmaGroup.com.

For stock control enquiries please contact Dr. Reddy’s Laboratories (UK) Ltd Customer Services Team at 01482 389858 (or main switchboard at 01482 860228), or email customerserviceuk@drreddys.com.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.